RE:RE:RE:RE:Where are the cheerleaders ??? This stock historically has survived mainly on fumes and promises !
However, they did get a number of health canada licences approved for generic drugs so they miight well get approval for their tech. They seem to know their way around Health Canada bureaucracy .The question is can they monetize that into Long term growing revs.
They are probably right in their thinking that health care data collection will be a big deal and valuable for future policy making and decision making . The question remains is their tech flexible and comprehensive enough to catch a junk of this wave ?